Middle East and Africa Infertility Diagnostics Devices Market Report and Forecast 2024-2032

Middle East and Africa Infertility Diagnostics Devices Market Report and Forecast 2024-2032

Middle East and Africa Infertility Diagnostics Devices Market Report and Forecast 2024-2032

Middle East and Africa Infertility Diagnostics Devices Market Size

The global infertility diagnostics devices market size is expected to grow at a CAGR of 8.80% during the forecast period of 2024-2032, with the Middle East and Africa holding a significant market share. The market is driven by the increasing prevalence of infertility and the rising advancements in diagnostic technologies.

Middle East and Africa Infertility Diagnostics Devices Market Outlook

• The infertility rates in Saudi Arabia, the UAE, and the other GCC countries are experiencing a rise and are estimated to exceed the double of global average (35-40%). This growing prevalence of infertility issues is poised to fuel the demand for affordable and effective infertility diagnostic devices.
• One of the major Middle East and Africa infertility diagnostics devices market trends is the rising investments in infertility care and reproductive health services. For instance, in January 2024 , Dubai Investments purchased a 34.3% stake in Global Fertility Partners (GFP), which boasts a robust network of fertility and reproductive genetics centers across the Middle East.
• The market share is significantly influenced by the rising technological advancements including innovations in imaging devices and minimally invasive techniques coupled with the increasing integration of artificial intelligence and machine learning in infertility diagnostic tools.

Middle East and Africa Infertility Diagnostics Devices Market Analysis

Infertility diagnostics devices are used to assess and diagnose reproductive conditions that affect an individual's ability to conceive naturally. With the help of such devices, a comprehensive evaluation of male and female fertility factors can be carried out which ultimately facilitates early detection and targeted treatments for infertility. The market is witnessing a shift towards greater acceptance of accepting medical help for infertility issues. Further, the rising technological advancements including innovations in imaging devices and minimally invasive techniques coupled with the increasing integration of artificial intelligence and machine learning in diagnostic tools are significantly contributing to the Middle East and Africa infertility diagnostics devices market growth.

The market is impacted by the growing infertility rates which drive the need for affordable and effective infertility services and devices. According to the World Health Organisation (WHO), around 17.5% of the adult population which accounts for nearly 1 out of 6 adults worldwide are affected by infertility. Further, research suggests that the infertility rates in Saudi Arabia, the UAE, and the other GCC countries are experiencing a rise and are estimated to be double of the global average (35-40%). This growing prevalence of infertility issues, attributed to changing lifestyle choices, dietary patterns, and undiagnosed medical conditions, is poised to fuel the Middle East and Africa infertility diagnostics devices market demand in the forecast period.

One of the major market trends is the rising investments in infertility care and reproductive health services in the region. In January 2024 , Dubai Investments (a United Arab Emirates-based investment company) purchased a 34.3% stake in Global Fertility Partners (GFP), which boasts a robust network of fertility and reproductive genetics centers across the Middle East. GFP plans to use the financial backing to expand its presence in fertility and women’s health centers in the Middle East and North African countries and has secured around USD 60 million in equity financing, which is anticipated to boost the availability of specialized fertility tools and services including infertility diagnostic devices in the region. Such developments in the infertility sector are likely to augment the market share in the coming years.

Middle East and Africa Infertility Diagnostics Devices Market Segmentation  

The report offers a detailed analysis of the market based on the following segments:

Market Breakup by Product

Equipment

Media and Consumables

Accessories

Market Breakup by Procedure

In Vitro Fertilization

Intracytoplasmic Sperm Injection

Artificial Insemination

Fertility Surgeries

Others

Market Breakup by Patient Type

Female

Male

Market Breakup by Type

Sperm Separation Devices

Ovum Aspiration Pumps

Sperm Analyzer Systems

Micromanipulator Systems

Incubators

Cryosystems

Imaging Systems

Microscope

Others

Market Breakup by End User

Hospitals and Surgical Clinics

Cryobanks

Research Institutes

Others

Market Breakup by Country

• Saudi Arabia
• United Arab Emirates
• Nigeria
• South Africa
• Others

Leading Players in the Middle East and Africa Infertility Diagnostics Devices Market

The key features of the market report include funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Cooper Surgical, Inc.
• Eppendorf AG
• Hamilton Thorne, Inc
• INVO Bioscience
• Vitrolife
• Rocket Medical Plc
• Merck KgaA
• MedGyn Product
• Ivftech Aps
• AB Scientific Ltd

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

FAQs

• What is the Middle East and Africa infertility diagnostics devices market forecast outlook for 2024-2032?

The Middle East and Africa infertility diagnostics devices market is expected to be driven by the rising demand for the global infertility diagnostics devices market, which is anticipated to grow at a CAGR of 8.80% during the forecast period of 2024-2032.

• What are the major factors aiding the Middle East and Africa xx market demand?

The increasing prevalence of infertility and the rising advancements in diagnostic technologies are fuelling the demand for the market.

• What are the major Middle East and Africa infertility diagnostics devices market trends?

One of the significant trends in the market is the rising investments in infertility care and reproductive health services. In January 2024, Dubai Investments purchased a 34.3% stake in Global Fertility Partners (GFP), which boasts a robust network of fertility and reproductive genetics centers across the Middle East.

• What is the market segmentation based on the product?

Based on the product, the market is segmented into equipment, media and consumables, along with accessories.

• What are the various procedures available in the market?

Procedures available in the market include in vitro fertilization, intracytoplasmic sperm injection, artificial insemination, and fertility surgeries, among others.

• What is the market breakup by patient type?

By patient type, the market is divided into female and male.

• What is the market segmentation based on the type?

The market breakup by type includes sperm separation devices, ovum aspiration pumps, sperm analyzer systems, micromanipulator systems, incubators, cryosystems, imaging systems, and microscopes, among others.

• What are the major end users of infertility diagnostics devices?

End users of the market are hospitals and surgical clinics, cryobanks, and research institutes, among others.

• What is the market segmentation by countries?

The market segmentation by countries includes Saudi Arabia, the United Arab Emirates, Nigeria, and South Africa, among others.

• Who are the key players involved in the Middle East and Africa infertility diagnostics devices market?

The key players in the market are Cooper Surgical, Inc., Eppendorf AG, Hamilton Thorne, Inc., INVO Bioscience, Vitrolife, Rocket Medical Plc, Merck KGaA, MedGyn Products, Ivftech Aps, and AB Scientific Ltd.

Meta description

The Middle East and Africa infertility diagnostics devices market is poised for growth, driven by the expansion of the global market, which is projected to grow at a CAGR of 8.80% during the forecast period of 2024-2032.

*Please Note:* The report will take 7 business days to complete, after order confirmation. Show more